Proinflammatory effects of diesel exhaust nanoparticles on scleroderma skin cells

Journal of Immunology Research

Volumn 2014, Issue , 2014, Pages

  Mastrofrancesco, A ^a   Alfe M ^b   Rosato, E ^b   Gargiulo, V ^b   Beatrice, C ^c   Di Blasio, G ^c   Zhang, B ^d   Su, D S ^d   Picardo, M ^a   Fiorito, S ^b  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^b CNR   (Italy)

^c ISTITUTO MOTORI CNR   (Italy)

^d INSTITUTE OF METAL RESEARCH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE A; GELATINASE B; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE ELASTASE; MATRILYSIN; MESSENGER RNA; NANOPARTICLE; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; COLLAGENASE; EXHAUST GAS; IL6 PROTEIN, HUMAN; PARTICULATE MATTER; SOOT; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DIESEL ENGINE; DISPERSION; EXHAUST GAS; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; INFLAMMATION; KERATINOCYTE; MOTOR VEHICLE; PARTICLE SIZE; POLLUTION; PROTEIN EXPRESSION; SCLERODERMA; SKIN CELL; SOOT; SUSPENSION; SYSTEMIC SCLEROSIS; ANALYSIS; CASE CONTROL STUDY; DOSE RESPONSE; DRUG EFFECTS; GENETICS; GENOTYPE ENVIRONMENT INTERACTION; ISOLATION AND PURIFICATION; METABOLISM; PARTICULATE MATTER; PATHOLOGY; PHARMACOLOGY; PRIMARY CELL CULTURE; SKIN; TOXICITY;

CASE-CONTROL STUDIES; COLLAGEN TYPE I; COLLAGEN TYPE III; COLLAGENASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; GENE EXPRESSION; GENE-ENVIRONMENT INTERACTION; HUMANS; INFLAMMATION; INTERLEUKIN-1ALPHA; INTERLEUKIN-6; INTERLEUKIN-8; KERATINOCYTES; NANOPARTICLES; PARTICULATE MATTER; PRIMARY CELL CULTURE; SCLERODERMA, SYSTEMIC; SKIN; SOOT; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VEHICLE EMISSIONS;

EID: 84903648101     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2014/138751     Document Type: Article

References (54)

1. Miller F. W., Pollard K. M., Parks C. G., Germolec D. R., Leung P. S. C., Selmi C., Humble M. C., Rose N. R., Criteria for environmentally associated autoimmune diseases. Journal of Autoimmunity 2012 39 4 253 258 2-s2.0-84869864007 10.1016/j.jaut.2012.05.001
2. Selmi C., Lu Q., Humble M. C., Heritability versus the role of the environment in autoimmunity. Journal of Autoimmunity 2012 39 4 249 252 2-s2.0-84869886531 10.1016/j.jaut.2012.07.011
3. Mora G. F., Systemic sclerosis: environmental factors. The Journal of Rheumatology 2009 36 11 2383 2396 2-s2.0-70450173918 10.3899/jrheum.090207
4. Javierre B. M., Hernando H., Ballestar E., Environmental triggers and epigenetic deregulation in autoimmune disease. Discovery Medicine 2011 12 67 535 545 2-s2.0-84865587194
5. Costenbader K. H., Gay S., Alarcón-Riquelme M. E., Iaccarino L., Doria A., Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? Autoimmunity Reviews 2012 11 8 604 609 2-s2.0-84861483169 10.1016/j.autrev.2011.10.022
6. Varga J., Abraham D., Systemic sclerosis: a prototypic multisystem fibrotic disorder. Journal of Clinical Investigation 2007 117 3 557 567 2-s2.0-33847348491 10.1172/JCI31139 (Pubitemid 46348510)
7. Gabrielli A., Avvedimento E. V., Krieg T., Mechanisms of disease: scleroderma. The New England Journal of Medicine 2009 360 19 1989 2003 2-s2.0-65649132626 10.1056/NEJMra0806188
8. Gilliam A., Scleroderma. Current Directions in Autoimmunity 2008 10 258 279 2-s2.0-49049100342 10.1159/000131502
9. Randone S. B., Guiducci S., Cerinic M. M., Systemic sclerosis and infections. Autoimmunity Reviews 2008 8 1 36 40 2-s2.0-54549122563 10.1016/j.autrev.2008.07.022
10. Selmi C., Leung P. S. C., Sherr D. H., Diaz M., Nyland J. F., Monestier M., Rose N. R., Gershwin M. E., Mechanisms of environmental influence on human autoimmunity: a national institute of environmental health sciences expert panel workshop. Journal of Autoimmunity 2012 39 4 272 284 10.1016/j.jaut.2012.05.007
11. Dospinescu P., Jones G. T., Basu N., Environmental risk factors in systemic sclerosis. Current Opinion in Rheumatology 2013 25 2 179 183 2-s2.0-84873407864 10.1097/BOR.0b013e32835cfc2d
12. Marie I., Gehanno J. F., Bubenheim M., Duval-Modeste A. B., Joly P., Dominique S., Bravard P., Noël D., Cailleux A. F., Weber J., Lagoutte P., Benichou J., Levesque H., Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmunity Reviews 2014 13 14 151 156 10.1016/j.autrev.2013.10.002
13. Donaldson K., Tran L., Jimenez L. A., Duffin R., Newby D. E., Mills N., MacNee W., Stone V., Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Particle and Fibre Toxicology 2005 2, article 10 2-s2.0-33845217749 10.1186/1743-8977-2-10 (Pubitemid 44848690)
14. Nel A., Air pollution-related illness: effects of particles. Science 2005 308 5723 804 806 2-s2.0-18244377974 10.1126/science.1108752 (Pubitemid 40629248)
15. Nemmar A., Al-Maskari S., Ali B. H., Al-Amri I. S., Cardiovascular and lung inflammatory effects induced by systemically administered diesel exhaust particles in rats. The American Journal of Physiology-Lung Cellular and Molecular Physiology 2007 292 3 L664 L670 2-s2.0-33847720649 10.1152/ajplung.00240.2006 (Pubitemid 46376984)
16. Beelen R., Hoek G., van den Brandt P. A., Goldbohm R. A., Fischer P., Schouten L. J., Armstrong B., Brunekreef B., Long-term exposure to traffic-related air pollution and lung cancer risk. Epidemiology 2008 19 5 702 710 2-s2.0-50549102617 10.1097/EDE.0b013e318181b3ca
17. Frank B., Schuster M. E., Schlögl R., Su D. S., Emission of highly activated soot particulate-the other side of the coin with modern diesel engines. Angewandte Chemie-International Edition 2013 52 10 2673 2677 2-s2.0-84874619198 10.1002/anie.201206093
18. Frank B., Schlögl R., Su D. S., Diesel soot toxification. Environmental Science and Technology 2013 47 7 3026 3027 2-s2.0-84875791842 10.1021/es4003873
19. Smijs T. G. M., Bouwstra J. A., Focus on skin as a possible port of entry for solid nanoparticles and the toxicological impact. Journal of Biomedical Nanotechnology 2010 6 5 469 484 2-s2.0-79953141208 10.1166/jbn.2010.1146
20. Vierkötter A., Krutmann J., Environmental influences on skin aging and ethnic-specific manifestations. Dermato-Endocrinology 2012 4 3 227 231 2-s2.0-84871878509 10.4161/de.19858
21. Slominski A. T., Zmijewski M. A., Skobowiat C., Zbytek B., Slominski R. M., Steketee J. D., Sensing the environment: regulation of localand global homeostasis by the skin's neuroendocrine system. Advances in Anatomy Embryology and Cell Biology 2012 212 115 2-s2.0-84862848789 10.1007/978-3-642-19683-6
22. Dang S. S., Serafino A., Müller J., Jentoft R. E., Schlögl R., Fiorito S., Cytotoxicity and inflammatory potential of soot particles of low-emission diesel engines. Environmental Science and Technology 2008 42 5 1761 1765 2-s2.0-40949086070 10.1021/es0716554 (Pubitemid 351416192)
23. Fiorito S., Mastrofrancesco A., Cardinali G., Rosato E., Salsano F., Su D. S., Serafino A., Picardo M., Effects of carbonaceous nanoparticles from low-emission and older diesel engines on human skin cells. Carbon 2011 49 15 5038 5048 2-s2.0-84857032217 10.1016/j.carbon.2011.07.022
24. Martin J. E., Assassi S., Diaz-Gallo L. M., A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci. Human Molecular Genetics 2013 22 19 4021 4029 10.1093/hmg/ddt248
25. Di Blasio G., Beatrice C., Molina S., Effect of port injected ethanol on combustion characteristics in a dual-fuel light duty diesel engine. SAE Technical Paper Series 2013 2013-01-1692 Society of Automotive Engineers
26. Müller J. O., Su D. S., Wild U., Schlögl R., Bulk and surface structural investigations of diesel engine soot and carbon black. Physical Chemistry Chemical Physics 2007 9 30 4018 4025 2-s2.0-34547100060 10.1039/b704850e
27. LeRoy E. C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T. A. Jr., Wollheim F., Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. The Journal of Rheumatology 1988 15 2 202 205 2-s2.0-0023854176 (Pubitemid 18073738)
28. van den Hoogen F., Khanna D., Fransen J., 2013 Classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis and Rheumatology 2013 65 11 2737 2747 10.1002/art.38098
29. Kovacs D., Flori E., Maresca V., Ottaviani M., Aspite N., Dell'Anna M. L., Panzella L., Napolitano A., Picardo M., D'Ischia M., The eumelanin intermediate 5,6-dihydroxyindole-2-carboxylic acid is a messenger in the cross-talk among epidermal cells. Journal of Investigative Dermatology 2012 132 4 1196 1205 2-s2.0-84858289501 10.1038/jid.2011.457
30. Zen M., Canova M., Campana C., Bettio S., Nalotto L., Rampudda M., Ramonda R., Iaccarino L., Doria A., The kaleidoscope of glucorticoid effects on immune system. Autoimmunity Reviews 2011 10 6 305 310 2-s2.0-79953164263 10.1016/j.autrev.2010.11.009
31. Iaccarino L., Ghirardello A., Canova M., Zen M., Bettio S., Nalotto L., Punzi L., Doria A., Anti-annexins autoantibodies: their role as biomarkers of autoimmune diseases. Autoimmunity Reviews 2011 10 9 553 558 2-s2.0-79957883066 10.1016/j.autrev.2011.04.007
32. Ranque B., Mouthon L., Geoepidemiology of systemic sclerosis. Autoimmunity Reviews 2010 9 5 A311 A318 2-s2.0-77949272156 10.1016/j.autrev. 2009.11.003
33. Tobón G. J., Youinou P., Saraux A., The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmunity Reviews 2010 9 5 A288 A292 2-s2.0-77949274520 10.1016/j.autrev.2009.11.019
34. Borchers A. T., Naguwa S. M., Shoenfeld Y., Gershwin M. E., The geoepidemiology of systemic lupus erythematosus. Autoimmunity Reviews 2010 9 5 A277 A287 2-s2.0-77649235610 10.1016/j.autrev.2009.12.008
35. Selmi C., Tsuneyama K., Nutrition, geoepidemiology, and autoimmunity. Autoimmunity Reviews 2010 9 5 A267 A270 2-s2.0-77649238845 10.1016/j.autrev. 2009.12.001
36. Selmi C., Autoimmunity in 2010. Autoimmunity Reviews 2011 10 12 725 732 2-s2.0-80053272236 10.1016/j.autrev.2011.06.004
37. Auchincloss A. H., Diez Roux A. V., Dvonch J. T., Brown P. L., Barr R. G., Daviglus M. L., Goff D. C. Jr., Kaufman J. D., O'Neill M. S., Associations between recent exposure to ambient fine particulate matter and blood pressure in the multi-ethnic study of atherosclerosis (MESA). Environmental Health Perspectives 2008 116 4 486 491 2-s2.0-45749104428 10.1289/ehp.10899 (Pubitemid 351864307)
38. Ostro B., Lipsett M., Reynolds P., Goldberg D., Hertz A., Garcia C., Henderson K. D., Bernstein L., Long-term exposure to constituents of fine particulate air pollution and mortality: results from the California teachers study. Environmental Health Perspectives 2010 118 3 363 369 2-s2.0-77649199460 10.1289/ehp.0901181
39. Raaschou-Nielsen O., Andersen Z. J., Hvidberg M., Jensen S. S., Ketzel M., Sørensen M., Loft S., Overvad K., Tjønneland A., Lung cancer incidence and long-term exposure to air pollution from traffic. Environmental Health Perspectives 2011 119 6 860 865 2-s2.0-79958799569 10.1289/ehp.1002353
40. Shah A. S., Langrish J. P., Nair H., McAllister D. A., Hunter A. L., Donaldson K., Newby D. E., Mills N. L., Global association of air pollution and heart failure: a systematic review and meta-analysis. The Lancet 2013 21 9897 1039 1048 2-s2.0-84879813382 10.1016/S0140-6736(13)60898-3
41. Aden N., Nuttall A., Shiwen X., de Winter P., Leask A., Black C. M., Denton C. P., Abraham D. J., Stratton R. J., Epithelial cells promote fibroblast activation via IL-1 in systemic sclerosis. Journal of Investigative Dermatology 2010 130 9 2191 2200 2-s2.0-77955713805 10.1038/jid.2010.120
42. Feghali C. A., Bost K. L., Boulware D. W., Levy L. S., Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. The Journal of Rheumatology 1992 19 8 1207 1211 2-s2.0-0026767273
43. Hasegawa M., Fujimoto M., Matsushita T., Hamaguchi Y., Takehara K., Sato S., Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis. Clinical Rheumatology 2011 30 2 231 237 2-s2.0-79954450466 10.1007/s10067-010-1610-4
44. Khan K., Xu S., Nihtyanova S., Derrett-Smith E., Abraham D., Denton C. P., Ong V. H., Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis. Annals of the Rheumatic Diseases 2012 71 7 1235 1242 2-s2.0-84862520877 10.1136/annrheumdis-2011-200955
45. Kim W. U., Min S. Y., Cho M. L., Hong K., Shin Y., Park S., Cho C., Elevated matrix metalloproteinase-9 in patients with systemic sclerosis. Arthritis Research & Therapy 2005 7 1 R71 R79 2-s2.0-28244481204
46. Manetti M., Guiducci S., Romano E., Bellando-Randone S., Conforti M. L., Ibba-Manneschi L., Matucci-Cerinic M., Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage. Annals of the Rheumatic Diseases 2012 71 6 1064 1072 2-s2.0-84860917548 10.1136/annrheumdis-2011-200837
47. Verslegers M., Lemmens K., van Hove I., Moons L., Matrix metalloproteinase-2 and -9 as promising benefactors in development, plasticity and repair of the nervous system. Progress in Neurobiology 2013 105 60 78 2-s2.0-84878109046 10.1016/j.pneurobio.2013.03.004
48. Peng W. J., Yan J. W., Wan Y. N., Wang B., Tao J., Yang G., Pan H., Wang J., Matrix metalloproteinases: a review of their structure and role in systemic sclerosis. Journal of Clinical Immunology 2012 32 6 1409 1414 2-s2.0-84878225353 10.1007/s10875-012-9735-7
49. Sawicki G., Intracellular regulation of matrix metalloproteinase-2 activity: new strategies in treatment and protection of heart subjected to oxidative stress. Scientifica 2013 2013 12 130451 10.1155/2013/130451
50. Moinzadeh P., Krieg T., Hellmich M., Brinckmann J., Neumann E., Müller-Ladner U., Kreuter A., Dumitrescu D., Rosenkranz S., Hunzelmann N., Elevated MMP-7 levels in patients with systemic sclerosis: correlation with pulmonary involvement. Experimental Dermatology 2011 20 9 770 773 2-s2.0-80051664850 10.1111/j.1600-0625.2011.01321.x
51. LeRoy E. C., Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast. Journal of Clinical Investigation 1974 54 4 880 889 2-s2.0-0016302998
52. Uitto J., Bauer E. A., Eisen A. Z., Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. Journal of Clinical Investigation 1979 64 4 921 930 2-s2.0-0018716011 (Pubitemid 10232568)
53. Peltonen J., Kahari L., Uitto J., Jimenez S. A., Increased expression of type VI collagen genes in systemic sclerosis. Arthritis and Rheumatism 1990 33 12 1829 1835 2-s2.0-0025641313 10.1002/art.1780331211
54. Kuroda K., Shinkai H., Gene expression of types I and III collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Archives of Dermatological Research 1997 289 10 567 572 2-s2.0-0030668134 10.1007/s004030050241 (Pubitemid 27477648)